EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Harnessing PHGDH Inhibition for Cancer Therapy: Mechanisms, SAR, Computational Aspects, and Clinical Potential

Md Mustahidul Islam, Shivani Kasana, Sakshi Priya, Balak Das Kurmi iD, Ghanshyam Das Gupta, Preeti Patel iD

Archiv der Pharmazie · 2025

DOI: 10.1002/ardp.70083 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Md Mustahidul Islam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, India. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents, Phosphoglycerate Dehydrogenase, Enzyme Inhibitors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 106 Literaturangaben. Gefördert von: The study was supported by the ICMR New Delhi, India (ID: 2021-10799, Proposal Sanc. No-5/13/20/2022/NCD-III)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

3‐Phosphoglycerate dehydrogenase (PHGDH) is a key enzyme in the serine biosynthesis pathway, supporting cancer cell growth, survival, and proliferation. Its overexpression is frequently observed in aggressive cancers such as breast cancer, melanoma, and glioma, where it drives tumor growth, metastasis, and resistance to oxidative stress. Targeting PHGDH with small‐molecule inhibitors has emerged as a promising therapeutic strategy. Notable inhibitors like NCT‐503, CBR‐5884, Azacoccone E, and Ixocarpalactone A, along with covalent inhibitors such as Withangulatin A, exhibit potent anticancer activity by limiting serine availability and inducing apoptosis. Gene‐silencing techniques, including RNA interference (RNAi) and CRISPR/Cas9, further validate PHGDH as a therapeutic target. Advances in computational methods and structure–activity relationship (SAR) analysis have accelerated the discovery of selective PHGDH inhibitors, offering insights into binding mechanisms and facilitating rational drug design. However, cancer cells can activate alternative metabolic pathways, such as glutaminolysis, to evade PHGDH inhibition. Thus, combination therapies targeting multiple metabolic nodes are being explored to enhance efficacy and overcome resistance. Ongoing research focuses on optimizing PHGDH inhibitors through virtual screening, QSAR modeling, and clinical trials, aiming to integrate them into precision oncology and develop effective therapies for patients with high PHGDH expression or specific metabolic profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsPhosphoglycerate DehydrogenaseEnzyme InhibitorsHumansStructure-Activity RelationshipAnimalsMolecular StructureCell ProliferationDrug Design

Stichwörter der Autor:innen

PHGDHcancer metabolismoxidative stressserine biosynthesistargeted therapy

Substanzen

Antineoplastic AgentsPhosphoglycerate DehydrogenaseEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, India.
  • Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab, India.

ORCID-Profile: Balak Das Kurmi, Preeti Patel

Förderung

  • The study was supported by the ICMR New Delhi, India (ID: 2021-10799, Proposal Sanc. No-5/13/20/2022/NCD-III).

Zitieren

APA

Islam, M. M., Kasana, S., Priya, S., Kurmi, B. D., Gupta, G. D., & Patel, P. (2025). Harnessing PHGDH Inhibition for Cancer Therapy: Mechanisms, SAR, Computational Aspects, and Clinical Potential. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70083

Vancouver

Islam MM, Kasana S, Priya S, Kurmi BD, Gupta GD, Patel P. Harnessing PHGDH Inhibition for Cancer Therapy: Mechanisms, SAR, Computational Aspects, and Clinical Potential. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70083

BibTeX
@article{Islam2025,
  author = {Islam, Md Mustahidul and Kasana, Shivani and Priya, Sakshi and Kurmi, Balak Das and Gupta, Ghanshyam Das and Patel, Preeti},
  title = {Harnessing PHGDH Inhibition for Cancer Therapy: Mechanisms, SAR, Computational Aspects, and Clinical Potential},
  journal = {Archiv der Pharmazie},
  year = {2025},
  doi = {10.1002/ardp.70083}
}
Kostenlos starten →